Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 141


Implications of HLA-allele associations for the study of type IV drug hypersensitivity reactions.

Sullivan A, Watkinson J, Waddington J, Park BK, Naisbitt DJ.

Expert Opin Drug Metab Toxicol. 2018 Mar;14(3):261-274. doi: 10.1080/17425255.2018.1441285. Epub 2018 Feb 22. Review.


Liraglutide and Renal Outcomes in Type 2 Diabetes.

Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators.

N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011.


Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.

Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, Pratley RE, Haahr PM, Lange M, Brown-Frandsen K, Moses A, Skibsted S, Kvist K, Buse JB; DEVOTE Study Group.

N Engl J Med. 2017 Aug 24;377(8):723-732. doi: 10.1056/NEJMoa1615692. Epub 2017 Jun 12.


Elevated PTTG and PBF predicts poor patient outcome and modulates DNA damage response genes in thyroid cancer.

Read ML, Fong JC, Modasia B, Fletcher A, Imruetaicharoenchoke W, Thompson RJ, Nieto H, Reynolds JJ, Bacon A, Mallick U, Hackshaw A, Watkinson JC, Boelaert K, Turnell AS, Smith VE, McCabe CJ.

Oncogene. 2017 Sep 14;36(37):5296-5308. doi: 10.1038/onc.2017.154. Epub 2017 May 15.


Adenoid Cystic Carcinoma of Trachea.

Varghese A, Suneha S, Watkinson JC.

Indian J Surg. 2017 Feb;79(1):67-69. doi: 10.1007/s12262-016-1457-2. Epub 2016 Feb 13.


Metastatic Papillary Thyroid Carcinoma With Adjacent BRAF (V600E)-Mutated Squamous Cell Carcinoma.

Rupani A, Hughes OR, Watkinson J, Nutting CM, Thway K.

Int J Surg Pathol. 2017 May;25(3):243-245. doi: 10.1177/1066896916674811. Epub 2016 Oct 21. No abstract available.


The Psychological Benefits of Being Authentic on Facebook.

Grieve R, Watkinson J.

Cyberpsychol Behav Soc Netw. 2016 Jul;19(7):420-5. doi: 10.1089/cyber.2016.0010.


Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators.

N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13.


Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.

Smith J, Read ML, Hoffman J, Brown R, Bradshaw B, Campbell C, Cole T, Navas JD, Eatock F, Gundara JS, Lian E, Mcmullan D, Morgan NV, Mulligan L, Morrison PJ, Robledo M, Simpson MA, Smith VE, Stewart S, Trembath RC, Sidhu S, Togneri FS, Wake NC, Wallis Y, Watkinson JC, Maher ER, McCabe CJ, Woodward ER.

Hum Mol Genet. 2016 May 1;25(9):1836-45. doi: 10.1093/hmg/ddw057. Epub 2016 Mar 3.


Development and feasibility study of very brief interventions for physical activity in primary care.

Pears S, Morton K, Bijker M, Sutton S, Hardeman W; VBI Programme Team.

BMC Public Health. 2015 Apr 8;15:333. doi: 10.1186/s12889-015-1703-8. Erratum in: BMC Public Health. 2015;15(1):1140.


Guidelines for the management of thyroid cancer.

Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, Gilbert J, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold K, Taylor J, Thakker RV, Watkinson J, Williams GR; British Thyroid Association.

Clin Endocrinol (Oxf). 2014 Jul;81 Suppl 1:1-122. doi: 10.1111/cen.12515. No abstract available.


Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up.

Mehanna H, Al-Maqbili T, Carter B, Martin E, Campain N, Watkinson J, McCabe C, Boelaert K, Franklyn JA.

J Clin Endocrinol Metab. 2014 Aug;99(8):2834-43. doi: 10.1210/jc.2013-2118. Epub 2014 May 14. Review.


Re-operative thyroid surgery: a 20-year prospective cohort study at a tertiary referral centre.

Hardman JC, Smith JA, Nankivell P, Sharma N, Watkinson JC.

Eur Arch Otorhinolaryngol. 2015 Jun;272(6):1503-8. doi: 10.1007/s00405-014-3068-5. Epub 2014 May 11.


The presentation, natural history and outcome of T1 a/b thyroid cancer with regard to new grading systems.

Smith JA, Sharma N, Nankivell P, Watkinson JC.

Eur Arch Otorhinolaryngol. 2015 Feb;272(2):439-44. doi: 10.1007/s00405-014-2968-8. Epub 2014 Mar 19.


The PTTG1-binding factor (PBF/PTTG1IP) regulates p53 activity in thyroid cells.

Read ML, Seed RI, Fong JC, Modasia B, Ryan GA, Watkins RJ, Gagliano T, Smith VE, Stratford AL, Kwan PK, Sharma N, Dixon OM, Watkinson JC, Boelaert K, Franklyn JA, Turnell AS, McCabe CJ.

Endocrinology. 2014 Apr;155(4):1222-34. doi: 10.1210/en.2013-1646. Epub 2014 Feb 7.


Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors.

Smith VE, Sharma N, Watkins RJ, Read ML, Ryan GA, Kwan PP, Martin A, Watkinson JC, Boelaert K, Franklyn JA, McCabe CJ.

J Clin Endocrinol Metab. 2013 Jul;98(7):2876-86. doi: 10.1210/jc.2012-3640. Epub 2013 May 15.


Iodine or Not (IoN) for low-risk differentiated thyroid cancer: the next UK National Cancer Research Network randomised trial following HiLo.

Mallick U, Harmer C, Hackshaw A, Moss L; IoN Trial Management Group.

Clin Oncol (R Coll Radiol). 2012 Apr;24(3):159-61. doi: 10.1016/j.clon.2012.01.001. Epub 2012 Feb 7. No abstract available.


Regulation of human thyroid follicular cell function by inhibition of vascular endothelial growth factor receptor signalling.

Susarla R, Watkinson JC, Eggo MC.

Mol Cell Endocrinol. 2012 Apr 4;351(2):199-207. doi: 10.1016/j.mce.2011.12.009. Epub 2011 Dec 29.


Who should perform thyroid surgery? United Kingdom (UK) and United States (US) perspectives with recommendations.

Smith JA, Watkinson JC, Shaha A.

Eur Arch Otorhinolaryngol. 2012 Jan;269(1):1-4. doi: 10.1007/s00405-011-1794-5. Epub 2011 Oct 22. No abstract available.


Treatment of neonatal sepsis with intravenous immune globulin.

INIS Collaborative Group, Brocklehurst P, Farrell B, King A, Juszczak E, Darlow B, Haque K, Salt A, Stenson B, Tarnow-Mordi W.

N Engl J Med. 2011 Sep 29;365(13):1201-11. doi: 10.1056/NEJMoa1100441.

Supplemental Content

Loading ...
Support Center